US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Number of shares and votes in Apotea

The number of shares and votes in Apotea AB (publ) (“Apotea”) has changed as a result of the issues in kind carried out in connection with the listing of Apotea’s ordinary shares on Nasdaq Stockholm on 6 December 2024.Through the issues in kind, the total number of shares has increased with 2,522,304 shares, from 102,742,950 shares to 105,265,254 shares, and the number of votes has increased with 1,447,444.8, from 102,742,950 to 104,190,394.8. The total number of shares is divided into 104,070,966 ordinary shares and 1,194,288 class C shares. The share capital has increased by SEK 12,611.52,

Decision from IMY after inspection of Apotea AB (publ)

Swedish Authority for Privacy Protection (Sw. Integritetsskyddsmyndigheten,“IMY”) has concluded its investigation into Apotea AB (publ)’s (“Apotea”) processing of personal data and compliance with GDPR. This following a self-notification of a personal data breach submitted by Apotea. In the investigation of two other pharmacy players, who also made a self-notification, IMY decided to issue administrative fines.Today, IMY announced a decision after the supervision of Apotea. IMY states that "in a combined assessment, IMY finds that it is a matter of a minor violation" of article 32.1 in the

Exercise of the overallotment option in Apotea and end of the stabilisation period in advance

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.Carnegie Investment Bank AB (publ) (“Carnegie”) and Skandinaviska Enskilda Banken AB (publ) (“SEB”) have today notified Apotea AB (publ) (“Apotea” or the “Company”) and

Apotea announces the outcome of the offering and trading on Nasdaq Stockholm commences today

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.Apotea AB (publ) (“Apotea” or the “Company”), Sweden’s largest online pharmacy[1], today announces the outcome of the offering of ordinary shares in the Company (the “

Apotea publishes prospectus and announces the price for the listing on Nasdaq Stockholm

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.On 14 November 2024, Apotea AB (publ) (“Apotea” or the “Company”), Sweden’s largest online pharmacy, announced its intention to launch an initial public offering of the

Apotea intends to list its shares on Nasdaq Stockholm

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.Apotea AB (publ) [1] (“Apotea” or the “Company”), Sweden’s largest online pharmacy, announces its intention to launch an initial public offering of the Company’s ordinary

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe